Status:

TERMINATED

CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

Lead Sponsor:

Barts & The London NHS Trust

Conditions:

Hypoglycemia, Reactive

Hypoglycaemia Night

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Use of CGM to determine diagnosis in possible spontaneous or reactive hypoglycaemia. Use of CGM to aid treatment optimisation in spontaneous or reactive hypoglycaemia

Detailed Description

The human body's blood sugar levels are tightly controlled by the hormone insulin, produced by the pancreas. If the pancreas produces too much insulin, then the blood sugar will fall to low levels (hy...

Eligibility Criteria

Inclusion

  • phase 1 - under investigation for possible/probable hypoglycaemia
  • phase 2 - on medical therapy for established hypoglycaemia
  • Must be Able and willing to give informed consent. No vulnerable adults will be included.
  • Must be Aged \>18 years
  • Can be;
  • Any ethnicity
  • Any socio economic group
  • Either conventional gender, or non-binary.

Exclusion

  • Must not be unwilling or unable to give consent
  • Must not be unable to speak sufficient English to give consent and understand study requirements
  • Must not be Aged\<18 or \>90 years
  • Must not be lack capacity to consent
  • Must not have an underlying hepatic condition
  • Must not have a current excessive alcohol consumption (men regularly consuming \>50 units/week, women \>35 units/week)
  • Must not have Diabetes Mellitus
  • Must not be currently using Diabetic medication or insulin
  • Must not be currently pregnant
  • Must not be on haemo or peritoneal dialysis

Key Trial Info

Start Date :

December 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2023

Estimated Enrollment :

7 Patients enrolled

Trial Details

Trial ID

NCT04452396

Start Date

December 1 2019

End Date

January 31 2023

Last Update

December 12 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St Bartholomew's Hospital, dept of endocrinology

London, United Kingdom, EC1A 7BE